건강

비상장계속사업자

GUNGANG Co., Ltd.

이계혁

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

건강

Business Reg. No. 1978801179 · CEO 이계혁

I.Investment Overview

Target건강 (1978801179)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명건강
영문명GUNGANG Co., Ltd.
대표자이계혁
사업자등록번호1978801179
법인등록번호1601110318504
설립일2012.03.08

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW519.3202054520210.520225.620244.92025
영업이익100M KRW77.9202091.62021-19.12022-7.72024-8.42025
순이익100M KRW63.7202065.22021-20.82022-48.62024-11.32025
Item20252024202220212020
자산총계186.7억원137.7억원148.1억원181.1억원575.4억원
부채총계138.3억원77.9억원35.9억원48.1억원507.7억원
자본총계48.4억원59.8억원112.2억원133억원67.8억원
매출액4.9억원5.6억원5,282만원545억원519.3억원
영업이익-8.4억원-7.7억원-19.1억원91.6억원77.9억원
순이익-11.3억원-48.6억원-20.8억원65.2억원63.7억원

VI.Financial Ratios

FY2025 basis

-170.95%

영업이익률

-231.36%

순이익률

-6.07%

ROA

-23.41%

ROE

285.55%

부채비율

25.94%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

건강 투심보고서 | Alpha Lenz